Physician profile
Sylvie Pham
NPI 1518337914
$5,322.96
in general payments reported to CMS, 2019-2025
12 companies · $533 in 2025
The $533 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $220 · 2021: $240 · 2022: $138 · 2023: $2,547 · 2024: $1,309 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,967 · Travel and Lodging: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,967.41 |
| Travel and Lodging | $1,421.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,897.50 | 2019-2025 | Dailies Aqua Comfort Plus, Air Optix, Dailies Total1 Multifocal |
| Bausch & Lomb Americas INC. | $1,111.89 | 2023-2025 | Infuse, Xiidra, Miebo |
| Coopervision INC. | $527.68 | 2022-2024 | Misight Contact Lens, Myday Contact Lens, Paragon Crt |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $503.39 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $399.98 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $246.77 | 2023-2024 | Cequa |
| Glaukos Corporation | $168.77 | 2025 | Photrexa Viscous and Photrexa |
| Horizon Therapeutics Plc | $151.59 | 2023 | Tepezza |
| Amgen INC. | $124.99 | 2024 | Tepezza |
| Mallinckrodt Hospital Products INC. | $121.36 | 2023 | Acthar |
| Oyster Point Pharma, INC. | $44.97 | 2022-2024 | Ryzumvi, Tyrvaya |
| Abbvie INC. | $24.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvie Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.